Abstract
Serotonin (5-HT) binding sites from bovine and rat cerebral cortex membranes share pharmacological properties that allow both to be subclassified by the same criteria. We show here that [3H]5-HT binding sites from human cortex also possess pharmacological properties that follow the same subclassification scheme as for bovine and rat cortex. In addition, we show that solubilized 5-HT1 and 5-HT3 sites from all three species have an s20,w value of 3.4. Despite these similar pharmacological and physical characteristics, we can demonstrate antigenic differences between receptor types and species. Human 5-HT1A sites can be distinguished from human 5-HT1B, 5-HT2, and 5-HT3 sites and from equivalent sites in rat and bovine cortex. The anti-human 5-HT1A antibodies were discovered in the blood of an autistic child and may have clinical or etiologic significance for this disorder.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Almon R. R., Andrew C. G., Appel S. H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science. 1974 Oct 4;186(4158):55–57. doi: 10.1126/science.186.4158.55. [DOI] [PubMed] [Google Scholar]
- Fillion G. M., Rousselle J. C., Fillion M. P., Beaudoin D. M., Goiny M. R., Deniau J. M., Jacob J. J. High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding. Mol Pharmacol. 1978 Jan;14(1):50–59. [PubMed] [Google Scholar]
- Lindstrom J., Tzartos S., Gullick W., Hochschwender S., Swanson L., Sargent P., Jacob M., Montal M. Use of monoclonal antibodies to study acetylcholine receptors from electric organs, muscle, and brain and the autoimmune response to receptor in myasthenia gravis. Cold Spring Harb Symp Quant Biol. 1983;48(Pt 1):89–99. doi: 10.1101/sqb.1983.048.01.012. [DOI] [PubMed] [Google Scholar]
- Ornitz E. M., Ritvo E. R. The syndrome of autism: a critical review. Am J Psychiatry. 1976 Jun;133(6):609–621. doi: 10.1176/ajp.133.6.609. [DOI] [PubMed] [Google Scholar]
- Pedigo N. W., Yamamura H. I., Nelson D. L. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem. 1981 Jan;36(1):220–226. doi: 10.1111/j.1471-4159.1981.tb02397.x. [DOI] [PubMed] [Google Scholar]
- Peroutka S. J., Snyder S. H. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain. Brain Res. 1981 Mar 16;208(2):339–347. doi: 10.1016/0006-8993(81)90562-x. [DOI] [PubMed] [Google Scholar]
- SCHAIN R. J., FREEDMAN D. X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr. 1961 Mar;58:315–320. doi: 10.1016/s0022-3476(61)80261-8. [DOI] [PubMed] [Google Scholar]
- Stahl S. M., Woo D. J., Mefford I. N., Berger P. A., Ciaranello R. D. Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. Am J Psychiatry. 1983 Jan;140(1):26–30. doi: 10.1176/ajp.140.1.26. [DOI] [PubMed] [Google Scholar]
- Strader C. D., Pickel V. M., Joh T. H., Strohsacker M. W., Shorr R. G., Lefkowitz R. J., Caron M. G. Antibodies to the beta-adrenergic receptor: attenuation of catecholamine-sensitive adenylate cyclase and demonstration of postsynaptic receptor localization in brain. Proc Natl Acad Sci U S A. 1983 Apr;80(7):1840–1844. doi: 10.1073/pnas.80.7.1840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Todd R. D., Douglas M. G. Structure of the yeast mitochondrial adenosine triphosphatase. Results of trypsin degradation. J Biol Chem. 1981 Jul 10;256(13):6990–6994. [PubMed] [Google Scholar]
- VandenBerg S. R., Allgren R. L., Todd R. D., Ciaranello R. D. Solubilization and characterization of high-affinity [3H]serotonin binding sites from bovine cortical membranes. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3508–3512. doi: 10.1073/pnas.80.11.3508. [DOI] [PMC free article] [PubMed] [Google Scholar]